FLGT

Fulgent Genetics (FLGT)

Fulgent Genetics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:FLGT

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/05	05 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FLGT	Fulgent Genetics Inc
2024/06/05	05 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FLGT	Fulgent Genetics Inc
2024/06/03	21 : 00	Business Wire	Fulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck Cancer	NASDAQ:FLGT	Fulgent Genetics Inc
2024/05/29	05 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FLGT	Fulgent Genetics Inc
2024/05/29	05 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FLGT	Fulgent Genetics Inc
2024/05/24	21 : 00	Business Wire	Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting	NASDAQ:FLGT	Fulgent Genetics Inc
2024/05/21	07 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FLGT	Fulgent Genetics Inc
2024/05/21	07 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FLGT	Fulgent Genetics Inc
2024/05/17	05 : 29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FLGT	Fulgent Genetics Inc
2024/05/15	05 : 05	Business Wire	Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics	NASDAQ:FLGT	Fulgent Genetics Inc
2024/05/08	05 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FLGT	Fulgent Genetics Inc
2024/05/03	20 : 00	Business Wire	Fulgent Reports First Quarter 2024 Financial Results	NASDAQ:FLGT	Fulgent Genetics Inc
2024/04/12	05 : 05	Business Wire	Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024	NASDAQ:FLGT	Fulgent Genetics Inc
2024/03/06	06 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FLGT	Fulgent Genetics Inc
2024/03/06	06 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FLGT	Fulgent Genetics Inc
2024/02/29	09 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FLGT	Fulgent Genetics Inc
2024/02/29	09 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FLGT	Fulgent Genetics Inc
2024/02/28	21 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FLGT	Fulgent Genetics Inc
2024/02/28	21 : 00	Business Wire	Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:FLGT	Fulgent Genetics Inc
2024/02/28	08 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FLGT	Fulgent Genetics Inc
2024/02/28	08 : 50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FLGT	Fulgent Genetics Inc
2024/02/13	22 : 00	Business Wire	Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024	NASDAQ:FLGT	Fulgent Genetics Inc
2024/02/10	08 : 09	Edgar (US Regulatory)	Form 5 - Annual statement of changes in beneficial ownership of securities	NASDAQ:FLGT	Fulgent Genetics Inc
2024/02/09	22 : 31	PR Newswire (US)	Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing	NASDAQ:FLGT	Fulgent Genetics Inc
2024/02/07	09 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FLGT	Fulgent Genetics Inc
2024/02/02	06 : 39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FLGT	Fulgent Genetics Inc
2024/01/31	06 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FLGT	Fulgent Genetics Inc
2024/01/31	06 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FLGT	Fulgent Genetics Inc
2023/12/14	10 : 49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FLGT	Fulgent Genetics Inc
2023/12/13	11 : 43	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FLGT	Fulgent Genetics Inc